Cancer cells survive therapy by dynamically rewiring their metabolism in response to nutrient availability, ...

The engagement establishes a multi-phase framework to support AI enabled capital efficient development of Teverelix, a next generation GnRH antagonist, as a first in class market product for acute ...

A large-scale international study, led by researchers from the Gray Faculty of Medical and Health Sciences at Tel Aviv ...

A team of cancer biologists led by Princeton’s Yibin Kang has resolved a confounding paradox about retinoids and cancer cells ...

Scientists at St. Jude Children's Research Hospital have revealed previously unappreciated roles for the retrotransposon LINE ...

The discovery could pave the way for new treatments, improved risk prediction, and earlier intervention for brain metastases.

Preliminary but promising.Those three words emerged as a recurring theme in conversations about several abstracts presented at this year’s ASH Annual Meeting and Exposition that examined the effects ...

The FDA-approved drug combination specifically targets low-grade serous ovarian cancer, which primarily affects younger women ...

Precision oncology advancements have led to new treatment options for gastric cancer, including immunotherapy and targeted ...

Cleveland Clinic researchers have discovered that bacteria inside cancerous tumors may be key to understanding why ...

Cancer is becoming a global crisis shaped less by biology than by inequality, risk exposure, and access to care.

A new study reveals how a single cancer protein may simultaneously drive tumor survival and metabolic control, uncovering a ...